Today: 29 June 2026

Roman Perkowski

Roman Perkowski is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Cracow University of Economics, he previously worked in investment research and corporate finance. His coverage helps readers understand the key forces driving global financial markets and emerging industries.

Delta eyes higher margins as jet fuel drops; fares may follow

Delta eyes higher margins as jet fuel drops; fares may follow

Delta Air Lines CEO Ed Bastian said Tuesday that cheaper jet fuel might not translate into lower fares if airlines in the U.S. can't grow seat supply. The margin story is still at play. Delta CEO Ed Bastian told Fox Business the industry can’t bring down ticket prices yet because the system is “logjammed.” Bastian said Delta had “no choice” but to raise fares when fuel costs went up. “Oil prices have come down now,” he said.
24 June 2026
·
IREN stock falls as Wall Street stays split on AI cloud payoff

IREN stock falls as Wall Street stays split on AI cloud payoff

IREN Limited slipped almost 4% Tuesday. The bigger story for investors is the wide range of Wall Street price targets as the company trades less as a bitcoin miner and more like an AI data-center play loaded with debt. IREN closed at $54.72, down 28.8% from its 52-week high at $76.87 but still trading close to five times above its 52-week low of $10.92. Shares moved in a $4.79 range during regular hours, about 8.8% of the last price. Market cap is listed at $19.56 billion.
24 June 2026
···
Novo Nordisk stock jumps premarket as $149 Wegovy pill hits U.S. market

Novo Nordisk (CPH:NOVO-B) gains as South Africa copycat order tops Ozempic, Wegovy local sales

Novo Nordisk’s B shares jumped 2.6% to 307.75 Danish crowns on Tuesday. The stock is up 5.1% since Friday’s close and has gained 9.9% over three sessions. The OMXC25 index in Copenhagen fell 0.07%. Novo put a new number out for investors: 84,500. That’s roughly how many compounded semaglutide units iDexis supplied each month in South Africa, the company told a court. Novo says that’s more than it sold of Ozempic and Wegovy combined in the country. A court order on Monday barred iDexis from compounding, supplying, and marketing the semaglutide products while they’re under regulatory review. Compounding in this case refers to pharmacies preparing or adjusting a drug for patients. The court filing doesn’t clarify if a unit from iDexis matches a Novo pack, so there’s no way to turn the number into revenue.
24 June 2026
····
Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

Archer Aviation (NYSE:ACHR) drops as revenue lags Wall Street targets

Archer Aviation shares fell 3.3% Tuesday, sending the air-taxi maker near its 52-week low again. The move spotlights a big valuation gap, with the company still at close to $4 billion in market value while first-quarter revenue was only $1.6 million. Shares of Archer wrapped up Tuesday at $5.25, about 9% above the 52-week low of $4.80 and still 64% off the 52-week high of $14.62. FactSet numbers cited by WSJ put the average analyst price target at $11.38, or 117% higher than the latest close. Volume hit 38.4 million shares, trailing the 65-day average, so this wasn't a heavy selloff session.
23 June 2026
·
Maase Stock Soars 24%—SEC Filing Sheds Light on Chaotic Details

Maase Stock Soars 24%—SEC Filing Sheds Light on Chaotic Details

Maase Inc jumped about 24% in recent Nasdaq trade Tuesday, bucking tech sector weakness. The China-based company put out interim numbers showing its pivot to AI computing, energy infrastructure, and smart hardware, which gave investors a new peek at progress. The stock was last seen at $22.16, up $4.31 on the day, after hitting $24.35 earlier. Volume came in around 443,000 shares.
23 June 2026
·
Tesla (NASDAQ:TSLA) shares fall after U.S. crash probe and hit to Europe sales

Tesla (NASDAQ:TSLA) shares fall after U.S. crash probe and hit to Europe sales

Tesla shares fell around 5% by midday Tuesday. A new U.S. safety probe and a slide in big tech stocks cut into the positive impact from the company’s rebound in European sales. Shares opened at $392.15, then traded at $384.63, after hitting an intraday low of $382.10. Tesla’s price-to-earnings ratio stood at about 353, using trailing earnings. Tesla’s delivery numbers are due in less than two weeks, so this matters to investors. Deliveries—cars that go to customers—will be the next clear check on whether demand is rebounding fast enough to keep up the stock’s high valuation.
23 June 2026
···
Plug Power (NASDAQ:PLUG) Shares Slip Again as Next Cash Challenge Draws Focus

Plug Power (NASDAQ:PLUG) Shares Slip Again as Next Cash Challenge Draws Focus

Plug Power Inc. stock was little changed Tuesday, with shares struggling to bounce back after dropping Monday. Investors looked at the hydrogen firm's higher revenues and better margins but stayed cautious on its ongoing cash requirements. The stock last traded near $2.79, off by less than a cent from yesterday’s close. Shares moved in a $2.58 to $2.83 range earlier, with volume around 27.4 million.
23 June 2026
··
Atlantic International (AIC) stock surges on news of Dutch contract, but details in filing raise questions

Atlantic International (AIC) stock surges on news of Dutch contract, but details in filing raise questions

Atlantic International Corp. jumped over 150% Tuesday late morning. The staffing firm said Circle8 Group, one of its units, landed a Dutch government deal valued at a minimum of $52 million. Shares traded near $1.12, up roughly 155%. Volume topped 291 million shares, according to market data. The timing was notable, coming less than a day after Atlantic turned in its overdue Form 10-Q and posted a big jump in Q1 revenue. The late filing triggered a Nasdaq non-compliance notice in May, but Atlantic said this filing should fix it.
23 June 2026
·
AMC Stock Drops After $200 Million Share Sale

AMC Stock Drops After $200 Million Share Sale

LEAWOOD, Kansas, June 23, 2026, 09:03 CDT AMC Entertainment shares dropped hard Tuesday. The cinema chain priced a $200 million stock offering, stoking new worries about dilution for shareholders even as the summer box office had been boosting sentiment on the stock.
23 June 2026
·
Ondas (NASDAQ:ONDS) slips; new defense orders up against resale share pressure

Ondas (NASDAQ:ONDS) Falls After $40M Defense Orders While Traders Watch Share Resale Filing

Ondas Inc. traded lower before the bell Tuesday. The stock slipped 2.47% to $8.67 as of 7:02 a.m. EDT, after finishing Monday at $8.89, down 4.10%. The company disclosed more than $40 million in fresh June orders, but market reaction stayed cautious after a new resale-share filing and weaker action across drone-linked names. Timing is key here. Ondas is shifting from its roots in industrial wireless and drones, aiming to be a defense-autonomy platform. New orders this quarter fueled a big jump in business. The company said June deals brought second-quarter order activity past $150 million. Orders cover counter-UAS systems, loitering munition systems, ground systems and defense services.
23 June 2026
··
Anthropic gets a lift from Micron ahead of IPO, uncertainty remains for investors

Anthropic gets a lift from Micron ahead of IPO, uncertainty remains for investors

Anthropic picked up support from Micron Technology on Monday, with the chipmaker set to supply memory and storage for the AI startup ahead of its expected IPO. Micron will also participate in Anthropic’s new funding round. Terms weren’t released. The partnership is in focus as Anthropic looks for expensive computing resources, while public shareholders push AI firms to justify heavy spending. On Monday, chipmakers moved higher, but some major tech names dropped. David Wagner at Aptus Capital said there’s a split between “those who are receiving the checks ... and those who are writing the checks.”
23 June 2026
···
Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

Amazon.com shares fell sharply on Monday as investors sold large technology stocks and questioned whether the industry’s heavy artificial-intelligence spending will pay off quickly enough. Amazon closed down 4.75% at $232.79 on Nasdaq, with after-hours trading at $233.20 at 7:01 p.m. EDT, Wall Street Journal market data showed. The move came a day before Amazon starts Prime Day, giving investors a near-term test of U.S. consumer demand just as they grow less patient with Big Tech’s AI bills. The Nasdaq Composite fell 1.32% and the S&P 500 lost 0.37%, while the Dow rose 0.29%, as declines in megacap technology shares outweighed gains in other sectors.
23 June 2026
··
Ford (NYSE:F) trades around $14 as Unifor labor talks put focus on margins

Ford (NYSE:F) trades around $14 as Unifor labor talks put focus on margins

Ford Motor Co. shares hung near the flat line Monday afternoon, trading at about $14 as the launch of Canadian labor talks ran into a generally weaker U.S. market. Shares were last at $14.07, just up 0.1%. Ford earlier hit $14.55. The SPDR S&P 500 ETF Trust, a main benchmark ETF, dipped 0.3%. Ford faces more than a typical labor schedule this week as Unifor started contract talks in Toronto on Monday. The union began negotiating with Ford, kicking off bargaining with the Detroit Three that includes General Motors and Stellantis. Unifor represents about 19,000 workers at the three automakers, according to Reuters.
22 June 2026
·
AbbVie grabs Apogee in $10.9 billion deal as buyouts speed up

AbbVie grabs Apogee in $10.9 billion deal as buyouts speed up

AbbVie said Monday it will buy Apogee Therapeutics for $10.9 billion in cash, picking up a late-stage eczema drug in what would be its biggest deal in over five years. The $135.11 per share offer is about 49% over Apogee’s June 18 close. Both companies’ boards signed off, aiming to wrap up the deal in the third quarter. AbbVie is buying Apogee as it’s still working to replace Humira sales lost to biosimilar rivals and getting ready for the patent cliffs looming on Skyrizi and Rinvoq. Immunology brought in more than $30 billion for AbbVie in 2025, but Humira sales dropped 49%. CEO Robert Michael called the deal an “excellent fit.” J.P. Morgan analyst Chris Schott cited appetite for late-stage growth assets. RBC’s Brian Abrahams said AbbVie is “an ideal acquirer.”
22 June 2026
···
IBM’s $15 Billion Move Catches Wall Street’s Eye Ahead of the Open

IBM slide puts AI growth bets in focus as Accenture outlook hits techs

IBM shares slid Monday, down 1.8% at $244.57, hit as Accenture’s softer guidance weighed on IT services stocks. Accenture dropped 5.2% to $121.34 in early afternoon New York trading. Worries over AI’s impact on consulting work drove debate on whether it can boost profits or makes some projects less profitable for IBM and rivals. This matters now as investors have stopped lumping every AI-related enterprise software name together. There’s a sharper divide showing up: self-scaling software versus consulting-heavy models that hinge on manpower and projects.
22 June 2026
···
Lime sets IPO target at $180.9 million, Uber stake and debt guarantee get attention

Lime sets IPO target at $180.9 million, Uber stake and debt guarantee get attention

Lime started its U.S. IPO roadshow on Monday, looking to sell 6,956,522 shares at $24 to $26 each and list on Nasdaq as “LIME.” Pricing at the high end would bring in around $180.9 million, counting stock from current shareholders, and set Lime’s valuation near $1.66 billion after the sale. The timing is key because the U.S. IPO market has started to come back after volatility linked to the Iran war. That shift is letting growth companies try for new listings. Lime isn't just another software name coming public. The deal is a test for shared micromobility in public markets — those short city trips under five miles on rented e-bikes and scooters — after years of high costs, local restrictions, and other players dropping out.
22 June 2026
·
CRH Plans $8.5 Billion Acquisition of Arcosa

CRH Plans $8.5 Billion Acquisition of Arcosa

CRH said it will buy Arcosa Inc. for around $8.5 billion in cash. The deal marks the building materials firm's biggest U.S. infrastructure move so far and boosts its position in products used for power-grid construction. Timing is key. U.S. construction suppliers are adding scale while infrastructure spending, energy grid projects and data center builds drive more demand to basic materials, quarries, and engineered products. The deal also comes as building products companies push for more consolidation.
22 June 2026
··
AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie said Monday it’s buying Apogee Therapeutics for $10.9 billion in cash, making this its largest deal since 2019. The company is looking to strengthen its immunology pipeline with Apogee’s long-acting immune-disease drugs. AbbVie and Apogee put out a joint release on the agreement, according to a securities filing. They expect the deal to close in the third quarter of 2026. It’s not a coincidence. Big pharma is stepping up biotech deals as expiring patents hit old blockbuster drugs, with over $200 billion in healthcare M&A announced this year, according to LSEG figures reported by the Financial Times.
22 June 2026
··
Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel Corporation is in focus Monday after jumping 10.64% to $133.99 last session. Early premarket quotes put the stock at $139.64, up 4.2% from that close. The gain comes after President Donald Trump said Apple would partner with Intel to design and make chips in the U.S. Reuters said Apple and Intel haven’t commented yet. For now, shares are trading up, with the deal details not out. The tough spot for NASDAQ: INTC bulls is how fast the stock’s valuation moved. Intel jumped $12.89 in a day, which, times 5.03 billion shares, put about $64.8 billion in market cap on in just one session. That’s nearly 4.8 times what Intel made in all of Q1 2026, at $13.6 billion in revenue. That’s the headline: the market wasn’t just reacting to a shot at Apple business. It shifted how it prices Intel Foundry’s credibility.
22 June 2026
··
Walmart’s Hawaiian Roll Recall Linked to Wrapper, Not Bread

Walmart’s Hawaiian Roll Recall Linked to Wrapper, Not Bread

BENTONVILLE, Ark., June 22, 2026, 03:21 CDT Walmart’s Great Value Hawaiian Roll four-packs are now included in a new FDA recall. United States Bakery, based in Oregon, reported an oily, sticky substance on the direct food-contact packaging. The recall covers 10,447 cases sent to 26 states. The concern centers on packaging that touches the rolls, not a confirmed problem with the bread itself.
22 June 2026
·
1 2 3 4 5 … 14
Go toTop